← Open Payments lookup

EUNICE NSOFOR: Open Payments

NPI 1821577354 · MANSFIELD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,331 in 38 payments from 8 companies in 2025. Trend: 2023 $627 · 2024 $775 · 2025 $1,331

Food & beverage: $1,331
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$438
Janssen Pharmaceuticals, Inc3$216
Supernus Pharmaceuticals, Inc.18$159
Otsuka America Pharmaceutical, Inc.3$153
E.R. Squibb & Sons, L.L.C.2$145
Teva Pharmaceuticals USA, Inc.1$140
ABBVIE INC.4$65
Axsome Therapeutics, Inc.1$15

Products named: CAPLYTA, INVEGA SUSTENNA, Qelbree, REXULTI, COBENFY, AUSTEDO XR, VRAYLAR, Auvelity.

Industry payments across TX — which companies pay providers there.